Menu
Live News EQUITY M impact

EXEL Downgraded

Truist Securities downgrades Exelixis to Hold and raises price target to $54

EXEL

Truist Securities analyst Gregory Renza downgrades Exelixis (NASDAQ: EXEL ) from Buy to Hold and raises the price target from $51 to $54.